Inari Medical Appoints Dr. Victor F. Tapson as VP of Medical Affairs

September 21, 2021—Inari Medical, Inc. a medical device company focused on the treatment of venous diseases, announced that the company has appointed Victor F. Tapson, MD, as Vice President of Medical Affairs.

The company stated that Dr. Tapson has devoted his medical career to patient care, research, and teaching in pulmonary hypertension and pulmonary embolism. He is an author of more than 200 peer-reviewed manuscripts and was involved in the development of the American Thoracic Society’s clinical practice guidelines for the diagnosis of venous thromboembolism (VTE).

“I am thrilled to be joining Inari Medical on its mission to revolutionize the treatment of pulmonary embolism and deep venous thrombosis,” stated Dr. Tapson in the company’s announcement.

Before joining Inari, Dr. Tapson was in practice at Cedars-Sinai Medical Center in Los Angeles, California, where he started the first Pulmonary Embolism Response Team (PERT) on the west coast. Dr. Tapson has been an officer and board member of the PERT Consortium and served as its first elected President.

Dr. Tapson spent more than 2 decades at Duke University Medical Center in Durham, North Carolina, where he was Professor of Medicine. At Duke, he focused on lung transplantation, pulmonary hypertension, and pulmonary embolism clinical research. He cofounded the Duke Lung Transplant Program, Duke Chronic Thromboembolic Pulmonary Hypertension Program, and Duke Pulmonary Vascular Disease Center, serving as its Director for 20 years.

Dr. Tapson is a graduate of Drexel University School of Medicine in Philadelphia, Pennsylvania. He completed his medical and pulmonology training at Duke University Medical Center and Boston University/Boston City Hospital in Boston, Massachusetts. He is board-certified in internal medicine and pulmonary disease and is fellowship-trained in pulmonary and critical care.

Inari’s Chief Medical Officer, Thomas Tu, MD, commented in the press release, “In order to establish a new gold standard for the treatment of VTE, not only [are] clinical data required but so is a change in systems of care. As a thought leader in the VTE space and pioneer of the PERT concept, Vic innately understands this and is uniquely qualified to enable Inari to execute.”